Brivaracetam is superior to levetiracetam in a rat model of post-hypoxic myoclonus

Journal of Neural Transmission

Volumn 114, Issue 12, 2007, Pages 1547-1551

  Tai, K K ^a   Truong, D D ^b  

^a LONG BEACH MEMORIAL MEDICAL CENTER   (United States)

^b Parkinson's and Movement Disorder Institute   (United States)

Author keywords

Animal model; Brivaracetam; Levetiracetam; Movement disorder; Post hypoxic myoclonus; Post hypoxic seizure

Indexed keywords

BRIVARACETAM; ETIRACETAM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUDITORY STIMULATION; BRAIN HYPOXIA; COMPARATIVE STUDY; CONTROLLED STUDY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG DOSE COMPARISON; DRUG DOSE ESCALATION; DRUG DOSE INCREASE; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; HEART ARREST; MALE; MYOCLONUS SEIZURE; NONHUMAN; PRIORITY JOURNAL; RAT; TREATMENT OUTCOME;

ANIMALS; ANOXIA; ANTICONVULSANTS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; EPILEPSIES, MYOCLONIC; HEART ARREST; PIRACETAM; PYRROLIDINONES; RATS; RATS, SPRAGUE-DAWLEY; SEIZURES;

EID: 36749053371     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-007-0788-3     Document Type: Article

References (27)

1. S Fahn 1978 Post-anoxic action myoclonus: improvement with valproic acid N Engl J Med 299 313 314
2. S Fahn 1979 Posthypoxic action myoclonus: review of the literature and report of two new cases with response to valproate and estrogen Adv Neurol 26 49 84
3. S Fahn 1986 Posthypoxic action myoclonus: literature review update Adv Neurol 43 157 169
4. C Fazio M Manfredi A Piccinelli 1975 Treatment of epileptic seizures with clonazepam. A reappraisal Arch Neurol 32 304 307
5. SJ Frucht M Trost Y Ma D Eidelberg 2004 The metabolic topography of posthypoxic myoclonus Neurology 62 1879 1881
6. P Genton P Gelisse 2000 Antimyoclonic effect of levetiracetam Epilept Disord 2 209 212
7. M Gillard P Chatelain B Fuks 2006 Binding characteristics of levetiracetam to synaptic vesicle protein 2A (SV2A) in human brain and in CHO cells expressing the human recombinant protein Eur J Pharmacol 536 102 108
8. AG Kanthasamy RR Matsumoto DD Truong 1995 Animal models of myoclonus Clin Neurosci 3 236 245
9. AG Kanthasamy BQ Nguyen DD Truong 2000 Animal model of posthypoxic myoclonus: II. Neurochemical, pathologic, and pharmacologic characterization Mov Disord 15 Suppl 1 31 38
10. K Kawai LP Penix N Kawahara CA Ruetzler I Klatzo 1995 Development of susceptibility to audiogenic seizures following cardiac arrest cerebral ischemia in rats J Cereb Blood Flow Metab 15 248 258
11. BM Kenda AC Matagne PE Talaga PM Pasau E Differding BI Lallemand AM Frycia FG Moureau HV Klitgaard MR Gillard B Fuks P Michel 2004 Discovery of 4-substituted pyrrolidone butanamides as new agents with significant antiepileptic activity J Med Chem 47 530 549
12. H Klitgaard 2001 Levetiracetam: the preclinical profile of a new class of antiepileptic drugs? Epilepsia 42 Suppl 4 13 18
13. GL Krauss A Bergin RE Kramer YW Cho SG Reich 2001 Suppression of post-hypoxic and post-encephalitic myoclonus with levetiracetam Neurology 56 411 412
14. GL Krauss T Betts B Abou-Khalil G Gergey H Yarrow A Miller 2003 Levetiracetam treatment of idiopathic generalised epilepsy Seizure 12 617 620
15. A Labate E Colosimo A Gambardella U Leggio R Ambrosio A Quattrone 2006 Levetiracetam in patients with generalised epilepsy and myoclonic seizures: an open label study Seizure 15 214 218
16. EA Lukyanetz VM Shkryl PG Kostyuk 2002 Selective blockade of N-type calcium channels by levetiracetam Epilepsia 43 9 18
17. BA Lynch N Lambeng K Nocka P Kensel-Hammes SM Bajjalieh A Matagne B Fuks 2004 The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam Proc Natl Acad Sci USA 101 9861 9866
18. B Malawska K Kulig 2005 Brivaracetam UCB Curr Opin Investig Drugs 6 740 746
19. I Niespodziany H Klitgaard DG Margineanu 2001 Levetiracetam inhibits the high-voltage-activated Ca(2+) current in pyramidal neurons of rat hippocampal slices Neurosci Lett 306 5 8
20. JM Rigo G Hans L Nguyen V Rocher S Belachew B Malgrange P Leprince G Moonen I Selak A Matagne H Klitgaard 2002 The anti-epileptic drug levetiracetam reverses the inhibition by negative allosteric modulators of neuronal GABA- and glycine-gated currents Br J Pharmacol 136 659 672
21. MA Rogawski 2006 Diverse mechanisms of antiepileptic drugs in the development pipeline Epilepsy Res 69 273 294
22. LM Specchio A Gambardella AT Giallonardo R Michelucci N Specchio G Boero A La Neve 2006 Open label, long-term, pragmatic study on levetiracetam in the treatment of juvenile myoclonic epilepsy Epilepsy Res 71 32 39
23. KK Tai DD Truong 2005 Post-hypoxic myoclonus induces Fos expression in the reticular thalamic nucleus and neurons in the brainstem Brain Res 1059 122 128
24. DD Truong RR Matsumoto PH Schwartz MJ Hussong CG Wasterlain 1994 Novel rat cardiac arrest model of posthypoxic myoclonus Mov Disord 9 201 206
25. DD Truong A Kanthasamy B Nguyen R Matsumoto P Schwartz 2000 Animal models of posthypoxic myoclonus: I. Development and validation Mov Disord 15 Suppl 1 26 30
26. DD Truong M Kirby A Kanthasamy RR Matsumoto 2002 Posthypoxic myoclonus animal models Adv Neurol 89 295 306
27. SJ Wallace 1998 Myoclonus and epilepsy in childhood: a review of treatment with valproate, ethosuximide, lamotrigine and zonisamide Epilepsy Res 29 147 154